JP2015528468A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015528468A5 JP2015528468A5 JP2015530126A JP2015530126A JP2015528468A5 JP 2015528468 A5 JP2015528468 A5 JP 2015528468A5 JP 2015530126 A JP2015530126 A JP 2015530126A JP 2015530126 A JP2015530126 A JP 2015530126A JP 2015528468 A5 JP2015528468 A5 JP 2015528468A5
- Authority
- JP
- Japan
- Prior art keywords
- alkylene
- alkyl
- heterocyclyl
- carbocyclyl
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims 34
- 239000001257 hydrogen Substances 0.000 claims 34
- 239000008194 pharmaceutical composition Substances 0.000 claims 33
- 150000001875 compounds Chemical class 0.000 claims 29
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 22
- 125000000623 heterocyclic group Chemical group 0.000 claims 17
- 229910052799 carbon Inorganic materials 0.000 claims 16
- 125000004432 carbon atom Chemical group C* 0.000 claims 13
- 125000005843 halogen group Chemical group 0.000 claims 13
- 208000015181 infectious disease Diseases 0.000 claims 13
- 229910052757 nitrogen Inorganic materials 0.000 claims 12
- 150000002431 hydrogen Chemical class 0.000 claims 11
- 125000004452 carbocyclyl group Chemical group 0.000 claims 10
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 10
- 125000001424 substituent group Chemical group 0.000 claims 10
- 125000001153 fluoro group Chemical group F* 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 8
- 125000004429 atom Chemical group 0.000 claims 7
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 125000002947 alkylene group Chemical group 0.000 claims 6
- 229910052760 oxygen Inorganic materials 0.000 claims 5
- 125000001309 chloro group Chemical group Cl* 0.000 claims 4
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 3
- 208000035473 Communicable disease Diseases 0.000 claims 3
- 241000202934 Mycoplasma pneumoniae Species 0.000 claims 3
- 206010057190 Respiratory tract infections Diseases 0.000 claims 3
- 241000193996 Streptococcus pyogenes Species 0.000 claims 3
- -1 fluoro compound Chemical group 0.000 claims 3
- 125000005842 heteroatom Chemical group 0.000 claims 3
- 206010040872 skin infection Diseases 0.000 claims 3
- 241000894007 species Species 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- 241001156739 Actinobacteria <phylum> Species 0.000 claims 2
- 241000193830 Bacillus <bacterium> Species 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 2
- 241001112696 Clostridia Species 0.000 claims 2
- 108010065152 Coagulase Proteins 0.000 claims 2
- 241000194032 Enterococcus faecalis Species 0.000 claims 2
- 241000194031 Enterococcus faecium Species 0.000 claims 2
- 241000606768 Haemophilus influenzae Species 0.000 claims 2
- 241000589242 Legionella pneumophila Species 0.000 claims 2
- 241000588655 Moraxella catarrhalis Species 0.000 claims 2
- 241000186359 Mycobacterium Species 0.000 claims 2
- 241000295644 Staphylococcaceae Species 0.000 claims 2
- 241000193985 Streptococcus agalactiae Species 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 229940115932 legionella pneumophila Drugs 0.000 claims 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- SOVUOXKZCCAWOJ-HJYUBDRYSA-N (4s,4as,5ar,12ar)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=C(NC(=O)CNC(C)(C)C)C(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O SOVUOXKZCCAWOJ-HJYUBDRYSA-N 0.000 claims 1
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 1
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 1
- ITHCSGCUQDMYAI-ZMIZWQJLSA-N 2-carboxy-D-arabinitol 1,5-bisphosphate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@](O)(COP(O)(O)=O)C(O)=O ITHCSGCUQDMYAI-ZMIZWQJLSA-N 0.000 claims 1
- 241000589291 Acinetobacter Species 0.000 claims 1
- 108700042778 Antimicrobial Peptides Proteins 0.000 claims 1
- 102000044503 Antimicrobial Peptides Human genes 0.000 claims 1
- 241000304886 Bacilli Species 0.000 claims 1
- 241000606125 Bacteroides Species 0.000 claims 1
- 241000589968 Borrelia Species 0.000 claims 1
- 241000589876 Campylobacter Species 0.000 claims 1
- 241001185363 Chlamydiae Species 0.000 claims 1
- 241000498849 Chlamydiales Species 0.000 claims 1
- 241000193403 Clostridium Species 0.000 claims 1
- 241000186216 Corynebacterium Species 0.000 claims 1
- 241000588921 Enterobacteriaceae Species 0.000 claims 1
- 241000194033 Enterococcus Species 0.000 claims 1
- 241000589989 Helicobacter Species 0.000 claims 1
- 241000589248 Legionella Species 0.000 claims 1
- 208000007764 Legionnaires' Disease Diseases 0.000 claims 1
- 241000186781 Listeria Species 0.000 claims 1
- 208000016604 Lyme disease Diseases 0.000 claims 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 claims 1
- 241001430197 Mollicutes Species 0.000 claims 1
- 241000589289 Moraxellaceae Species 0.000 claims 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 claims 1
- 241000204031 Mycoplasma Species 0.000 claims 1
- 241000204003 Mycoplasmatales Species 0.000 claims 1
- 241000187654 Nocardia Species 0.000 claims 1
- 241000606752 Pasteurellaceae Species 0.000 claims 1
- 206010035664 Pneumonia Diseases 0.000 claims 1
- 241000186429 Propionibacterium Species 0.000 claims 1
- 102100021486 Protein S100-G Human genes 0.000 claims 1
- 101710122252 Protein S100-G Proteins 0.000 claims 1
- 241000606651 Rickettsiales Species 0.000 claims 1
- 241000589973 Spirochaeta Species 0.000 claims 1
- 241000589970 Spirochaetales Species 0.000 claims 1
- 241000191940 Staphylococcus Species 0.000 claims 1
- 241000194017 Streptococcus Species 0.000 claims 1
- 239000004098 Tetracycline Substances 0.000 claims 1
- 241000589886 Treponema Species 0.000 claims 1
- 108010059993 Vancomycin Proteins 0.000 claims 1
- 241000607493 Vibrionaceae Species 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229940124307 fluoroquinolone Drugs 0.000 claims 1
- 229940041010 fourth-generation cephalosporins Drugs 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 229960003085 meticillin Drugs 0.000 claims 1
- 239000000178 monomer Substances 0.000 claims 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 claims 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 claims 1
- 229940041008 second-generation cephalosporins Drugs 0.000 claims 1
- 229960002180 tetracycline Drugs 0.000 claims 1
- 229930101283 tetracycline Natural products 0.000 claims 1
- 235000019364 tetracycline Nutrition 0.000 claims 1
- 229940072172 tetracycline antibiotic Drugs 0.000 claims 1
- 150000003522 tetracyclines Chemical class 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 229940041007 third-generation cephalosporins Drugs 0.000 claims 1
- 229960004089 tigecycline Drugs 0.000 claims 1
- 229960003165 vancomycin Drugs 0.000 claims 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 claims 1
- MYPYJXKWCTUITO-LYRMYLQWSA-O vancomycin(1+) Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C([O-])=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)[NH2+]C)[C@H]1C[C@](C)([NH3+])[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-O 0.000 claims 1
- 150000003952 β-lactams Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261695947P | 2012-08-31 | 2012-08-31 | |
| US61/695,947 | 2012-08-31 | ||
| PCT/US2013/057690 WO2014036502A2 (en) | 2012-08-31 | 2013-08-30 | Tetracycline compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018034611A Division JP6691157B2 (ja) | 2012-08-31 | 2018-02-28 | テトラサイクリン化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015528468A JP2015528468A (ja) | 2015-09-28 |
| JP2015528468A5 true JP2015528468A5 (enExample) | 2016-10-13 |
| JP6301335B2 JP6301335B2 (ja) | 2018-03-28 |
Family
ID=49170898
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015530126A Active JP6301335B2 (ja) | 2012-08-31 | 2013-08-30 | テトラサイクリン化合物 |
| JP2018034611A Active JP6691157B2 (ja) | 2012-08-31 | 2018-02-28 | テトラサイクリン化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018034611A Active JP6691157B2 (ja) | 2012-08-31 | 2018-02-28 | テトラサイクリン化合物 |
Country Status (27)
| Country | Link |
|---|---|
| US (3) | US9573895B2 (enExample) |
| EP (2) | EP3461809B1 (enExample) |
| JP (2) | JP6301335B2 (enExample) |
| KR (2) | KR102295673B1 (enExample) |
| CN (3) | CN108329312B (enExample) |
| AU (3) | AU2013308504B2 (enExample) |
| BR (1) | BR112015004523B1 (enExample) |
| CA (1) | CA2883238C (enExample) |
| CY (1) | CY1122744T1 (enExample) |
| DK (1) | DK2890673T3 (enExample) |
| EA (2) | EA036088B1 (enExample) |
| ES (1) | ES2712476T3 (enExample) |
| HR (1) | HRP20190268T1 (enExample) |
| HU (1) | HUE042600T2 (enExample) |
| IL (2) | IL237437B (enExample) |
| LT (1) | LT2890673T (enExample) |
| ME (1) | ME03329B (enExample) |
| MX (2) | MX390763B (enExample) |
| NZ (3) | NZ740051A (enExample) |
| PL (1) | PL2890673T3 (enExample) |
| PT (1) | PT2890673T (enExample) |
| RS (1) | RS58572B1 (enExample) |
| SG (2) | SG10201801703RA (enExample) |
| SI (1) | SI2890673T1 (enExample) |
| SM (1) | SMT201900096T1 (enExample) |
| TR (1) | TR201902057T4 (enExample) |
| WO (1) | WO2014036502A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2558512T3 (es) | 2008-08-08 | 2016-02-04 | Tetraphase Pharmaceuticals, Inc. | Compuestos de tetraciclina sustituida con C7-fluoro |
| WO2010129057A2 (en) | 2009-05-08 | 2010-11-11 | Tetraphase Pharmaceuticals, Inc. | Tetracycline compounds |
| HUE037852T2 (hu) | 2009-08-28 | 2018-09-28 | Tetraphase Pharmaceuticals Inc | Tetraciklin-vegyületek |
| SMT201900096T1 (it) * | 2012-08-31 | 2019-02-28 | Tetraphase Pharmaceuticals Inc | Composti di tetracicline |
| WO2018045084A1 (en) * | 2016-08-30 | 2018-03-08 | Tetraphase Pharmaceuticals, Inc. | Tetracycline compounds and methods of treatment |
| MA46567A (fr) | 2016-10-19 | 2019-08-28 | Tetraphase Pharmaceuticals Inc | Formes cristallines de l'éravacycline |
| CA3099888A1 (en) | 2018-07-27 | 2020-01-30 | Sandoz Ag | Process for preparing rapidly or very rapidly dissolving tablets comprising freely soluble api |
| CN113444070A (zh) * | 2021-07-28 | 2021-09-28 | 深圳市真味生物科技有限公司 | 一种由手性叔丁基亚磺酰胺合成手性尼古丁的制备方法 |
| CN115448849B (zh) * | 2022-11-10 | 2023-02-03 | 苏州富士莱医药股份有限公司 | 一种2-苄氧基-3-二苄基氨基-5-氟-6-甲基苯甲酸苯酯的制备方法 |
Family Cites Families (112)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE639292A (enExample) | ||||
| GB935384A (en) * | 1959-03-30 | 1963-08-28 | Pfizer & Co C | Tetracycline derivatives and preparation thereof |
| US3338963A (en) | 1960-10-28 | 1967-08-29 | American Cyanamid Co | Tetracycline compounds |
| GB1034933A (en) * | 1962-10-29 | 1966-07-06 | American Cyanamid Co | 4-demethylamino-4-substituted amino 6-demethyl tetracyclines |
| US3364123A (en) * | 1963-05-06 | 1968-01-16 | Squibb & Sons Inc | Production of 4n-demethyl-4n-ethyl tetracyclines |
| USRE26253E (en) | 1963-05-17 | 1967-08-15 | And z-alkylamino-g-deoxytetracycline | |
| GB1065715A (en) * | 1964-04-16 | 1967-04-19 | Pfizer & Co C | Tetracycline derivatives |
| US3247226A (en) * | 1964-07-06 | 1966-04-19 | American Cyanamid Co | 4-dimethylamino and 4-hydroxytetracycloxides |
| US3394178A (en) * | 1965-01-26 | 1968-07-23 | Merck & Co Inc | Nu-ethyloxytetracycline |
| GB1077598A (en) | 1965-05-12 | 1967-08-02 | Pfizer & Co C | Preparation of n-demethyl tetracyclines |
| US3304227A (en) | 1965-07-15 | 1967-02-14 | Loyal E Loveless | Antibiotic-containing animal feed |
| US3433709A (en) | 1965-12-07 | 1969-03-18 | American Cyanamid Co | Biological transformation of alpha-6-deoxytetracyclines to tetracyclines |
| US3849493A (en) * | 1966-08-01 | 1974-11-19 | Pfizer | D-ring substituted 6-deoxytetracyclines |
| US3824285A (en) * | 1967-09-13 | 1974-07-16 | Pfizer | 4-oxo-4-dedimethylaminotetracycline-4,6-hemiketals |
| US3947517A (en) | 1969-06-12 | 1976-03-30 | Research Corporation | Stereoselective introduction of tetracyclines hydroxyl group at 12(a) position in synthesis of tetracyclines |
| DE2437487A1 (de) | 1974-08-03 | 1976-02-19 | Merck Patent Gmbh | 7-methoxy-6-thia-tetracycline und verfahren zu ihrer herstellung |
| DE2442829A1 (de) * | 1974-09-06 | 1976-03-18 | Merck Patent Gmbh | Tetracyclische verbindungen und verfahren zu ihrer herstellung |
| YU290176A (en) | 1976-11-26 | 1982-05-31 | Pliva Zagreb | Process for preparing 4-dedimethylamino-4-arylsulfonamido-5a,6-anhydrotetracycline |
| US4666897A (en) | 1983-12-29 | 1987-05-19 | Research Foundation Of State University | Inhibition of mammalian collagenolytic enzymes by tetracyclines |
| US4935412A (en) | 1983-12-29 | 1990-06-19 | The Research Foundation Of State University Of New York | Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same |
| US4704383A (en) | 1983-12-29 | 1987-11-03 | The Research Foundation Of State University Of New York | Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same |
| US4925833A (en) | 1983-12-29 | 1990-05-15 | The Research Foundation Of State University Of New York | Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis |
| USRE34656E (en) | 1983-12-29 | 1994-07-05 | The Research Foundation Of State University Of New York | Use of tetracycline to enhance bone protein synthesis and/or treatment of bone deficiency |
| US5308839A (en) | 1989-12-04 | 1994-05-03 | The Research Foundation Of State University Of New York | Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline |
| JP3016587B2 (ja) | 1989-12-04 | 2000-03-06 | ザ・リサーチ・ファンデーション・オブ・ステート・ユニバーシティ・オブ・ニューヨーク | 非ステロイド抗炎症剤及びテトラサイクリンの配合 |
| US5770588A (en) | 1991-02-11 | 1998-06-23 | The Research Foundation Of State University Of New York | Non-antibacterial tetracycline compositions of the prevention and treatment of root caries |
| US5231017A (en) | 1991-05-17 | 1993-07-27 | Solvay Enzymes, Inc. | Process for producing ethanol |
| DE122006000058I2 (de) | 1991-10-04 | 2007-09-13 | Wyeth Corp | 7-Substituierte-9-substituierte Amino-6-Demethyl-6-Deoxy-Tetracycline |
| USRE40183E1 (en) | 1991-10-04 | 2008-03-25 | Wyeth Holdings Corporation | 7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines |
| US5494903A (en) | 1991-10-04 | 1996-02-27 | American Cyanamid Company | 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines |
| US5258371A (en) | 1992-05-29 | 1993-11-02 | Kuraray Co., Ltd. | Method to reduce connective tissue destruction |
| US6043225A (en) | 1992-06-12 | 2000-03-28 | Board Of Regents Of The University Of Washington | Diagnosis and treatment of arterial chlamydial granuloma |
| US5420272A (en) | 1992-08-13 | 1995-05-30 | American Cyanamid Company | 7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
| SG47520A1 (en) | 1992-08-13 | 1998-04-17 | American Cyanamid Co | New method for the production of 9-amino-6-demethyl-6-deoxytetracycline |
| US5442059A (en) | 1992-08-13 | 1995-08-15 | American Cyanamid Company | 9-[(substituted glycyl)amido)]-6-demethyl-6-deoxytetracyclines |
| US5284963A (en) | 1992-08-13 | 1994-02-08 | American Cyanamid Company | Method of producing 7-(substituted)-9-[(substituted glycyl)-amidol]-6-demethyl-6-deoxytetra-cyclines |
| US5328902A (en) | 1992-08-13 | 1994-07-12 | American Cyanamid Co. | 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
| DE69304292T2 (de) | 1992-11-17 | 1997-01-02 | Univ New York | Tetracycline inclusive nicht antimicrobiel wirksame, chemisch modifizierte Tetracycline hemmende exzessive Kollagenquervernetzung bei Diabetes |
| US5523297A (en) | 1993-03-02 | 1996-06-04 | The Research Foundation Of State University Of New York | Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines |
| US6043231A (en) | 1993-03-02 | 2000-03-28 | The Research Foundation Of State Univ. Of New York | Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines |
| US5371076A (en) | 1993-04-02 | 1994-12-06 | American Cyanamid Company | 9-[(substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
| US5668122A (en) | 1993-07-28 | 1997-09-16 | Fife; Rose S. | Method to treat cancer with tetracyclines |
| AU1279095A (en) | 1994-02-17 | 1995-09-04 | Pfizer Inc. | 9-(substituted amino)-alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics |
| US5574026A (en) | 1994-12-13 | 1996-11-12 | American Cyanamid Company | Methods for inhibiting angiogenesis proliferation of endothelial or tumor cells and tumor growth |
| US5843925A (en) | 1994-12-13 | 1998-12-01 | American Cyanamid Company | Methods for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth |
| US5834449A (en) | 1996-06-13 | 1998-11-10 | The Research Foundation Of State University Of New York | Treatment of aortic and vascular aneurysms with tetracycline compounds |
| US5827840A (en) | 1996-08-01 | 1998-10-27 | The Research Foundation Of State University Of New York | Promotion of wound healing by chemically-modified tetracyclines |
| US5789395A (en) | 1996-08-30 | 1998-08-04 | The Research Foundation Of State University Of New York | Method of using tetracycline compounds for inhibition of endogenous nitric oxide production |
| US5919774A (en) | 1996-12-10 | 1999-07-06 | Eli Lilly And Company | Pyrroles as sPLA2 inhibitors |
| US5837696A (en) | 1997-01-15 | 1998-11-17 | The Research Foundation Of State University Of New York | Method of inhibiting cancer growth |
| US5773430A (en) | 1997-03-13 | 1998-06-30 | Research Foundation Of State University Of New York | Serine proteinase inhibitory activity by hydrophobic tetracycline |
| US5929055A (en) | 1997-06-23 | 1999-07-27 | The Research Foundation Of State University Of New York | Therapeutic method for management of diabetes mellitus |
| JP2002501026A (ja) | 1998-01-23 | 2002-01-15 | トルスティーズ オブ トゥフツ カレッジ | 薬学的に活性の化合物及びその利用法 |
| US6277061B1 (en) | 1998-03-31 | 2001-08-21 | The Research Foundation Of State University Of New York | Method of inhibiting membrane-type matrix metalloproteinase |
| US6015804A (en) | 1998-09-11 | 2000-01-18 | The Research Foundation Of State University Of New York | Method of using tetracycline compounds to enhance interleukin-10 production |
| US5977091A (en) | 1998-09-21 | 1999-11-02 | The Research Foundation Of State University Of New York | Method of preventing acute lung injury |
| JP2002525299A (ja) | 1998-09-28 | 2002-08-13 | ザ リサーチ ファウンデーション オブ ステイト ユニヴァーシティ オブ ニューヨーク | 新規白内障形成抑制剤 |
| US6914057B1 (en) | 1998-09-28 | 2005-07-05 | The Research Foundation Of State University Of New York | Inhibitor of cataract formation |
| US5998390A (en) | 1998-09-28 | 1999-12-07 | The Research Foundation Of State University Of New York | Combination of bisphosphonate and tetracycline |
| US6231894B1 (en) | 1999-10-21 | 2001-05-15 | Duke University | Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase |
| AU2000257445A1 (en) | 2000-06-16 | 2002-01-02 | Trustees Of Tufts College | 7-n-substituted phenyl tetracycline compounds |
| ATE504562T1 (de) | 2000-07-07 | 2011-04-15 | Tufts College | 7-, 8- und 9-substitutierte tetracyclinverbindungen |
| IL153672A0 (en) | 2000-07-07 | 2003-07-06 | Tufts College | 7-substituted tetracycline compounds |
| SI1301467T1 (sl) | 2000-07-07 | 2007-02-28 | Tufts College | 9-substituirane minociklinske spojine |
| EP1368305B1 (en) | 2001-03-13 | 2008-08-13 | Paratek Pharmaceuticals, Inc. | 7, 9-substituted tetracycline compounds |
| WO2002072031A2 (en) | 2001-03-14 | 2002-09-19 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds as synergistic antifungal agents |
| CA2457234A1 (en) | 2001-03-14 | 2002-09-19 | Mark L. Nelson | Substituted tetracycline compounds as antifungal agents |
| DE60235083D1 (de) | 2001-04-24 | 2010-03-04 | Paratek Pharm Innc | Substituierte tetracyclin-verbindungen zur behandlung von malaria |
| US8088820B2 (en) | 2001-04-24 | 2012-01-03 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for the treatment of malaria |
| US20060194773A1 (en) | 2001-07-13 | 2006-08-31 | Paratek Pharmaceuticals, Inc. | Tetracyline compounds having target therapeutic activities |
| JP2004537544A (ja) | 2001-07-13 | 2004-12-16 | パラテック ファーマシューティカルズ インコーポレイテッド | 標的治療活性を有するテトラサイクリン化合物 |
| ES2551708T3 (es) | 2002-01-08 | 2015-11-23 | Paratek Pharmaceuticals, Inc. | Compuestos de 4-desdimetilamino tetraciclina |
| EP1482926A4 (en) | 2002-03-08 | 2006-04-12 | Paratek Pharm Innc | AMINO METHYL SUBSTITUTED TETRACYCLINE COMPOUNDS |
| WO2003079984A2 (en) | 2002-03-21 | 2003-10-02 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds |
| EA200900540A1 (ru) | 2002-07-12 | 2009-12-30 | Пэрэтек Фамэсьютикэлс, Инк. | Замещённые соединения тетрациклина, фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния у субъекта |
| CA2503446C (en) | 2002-10-24 | 2012-12-18 | Paratek Pharmaceuticals, Inc. | Methods of using substituted tetracycline compounds to modulate rna |
| AU2003287218C1 (en) | 2002-10-24 | 2010-07-15 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for the treatment of malaria |
| EP1648859B1 (en) | 2003-07-09 | 2013-02-27 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds |
| WO2005082860A1 (en) | 2004-02-27 | 2005-09-09 | National Research Council Of Canada | Tetracyclines and their use as calpain inhibitors |
| US7807842B2 (en) | 2004-05-21 | 2010-10-05 | President And Fellows Of Harvard College | Synthesis of tetracyclines and analogues thereof |
| EP2269991A3 (en) | 2004-10-25 | 2011-09-21 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds |
| WO2006047671A2 (en) * | 2004-10-25 | 2006-05-04 | Paratek Pharmaceuticals, Inc. | 4-aminotetracyclines and methods of use thereof |
| WO2006084265A1 (en) | 2005-02-04 | 2006-08-10 | Paratek Pharmaceuticals, Inc. | 11a, 12-DERIVATIVES OF TETRACYCLINE COMPOUNDS |
| AU2006214543A1 (en) | 2005-02-15 | 2006-08-24 | Wyeth | 9-substituted tetracyclines |
| JP2009502809A (ja) * | 2005-07-21 | 2009-01-29 | パラテック ファーマシューティカルズ インコーポレイテッド | １０−置換テトラサイクリンおよびその使用方法 |
| US9078811B2 (en) | 2006-01-24 | 2015-07-14 | Paratek Pharmaceuticals, Inc. | Methods of increasing oral bioavailability of tetracyclines |
| EP2016044B1 (en) | 2006-04-07 | 2020-06-10 | President and Fellows of Harvard College | Pentacycline derivatives for the treatment of infections |
| CA2652347A1 (en) | 2006-05-15 | 2007-11-22 | Paratek Pharmaceuticals, Inc. | Methods of regulating expression of genes or of gene products using substituted tetracycline compounds |
| US8440646B1 (en) | 2006-10-11 | 2013-05-14 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds for treatment of Bacillus anthracis infections |
| EP2479169B1 (en) | 2006-10-11 | 2014-12-03 | President and Fellows of Harvard College | Synthesis of Enone Intermediate |
| EP2450347B1 (en) | 2006-12-21 | 2015-06-24 | Paratek Pharmaceuticals, Inc. | Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections |
| TWI334106B (en) | 2006-12-27 | 2010-12-01 | Icp Electronics Inc | Apparatus for converting gray scale and method for the same |
| WO2008127722A1 (en) | 2007-04-12 | 2008-10-23 | Paratek Pharmaceuticals, Inc. | Methods for treating spinal muscular atrophy using tetracycline compounds |
| BRPI0813990A2 (pt) | 2007-07-06 | 2011-09-13 | Paratek Pharmaceuticals, Inc. | métodos para sintetizar compostos de minociclina substituìda |
| US7939513B2 (en) | 2007-09-07 | 2011-05-10 | Dr. Reddy's Laboratories Limited | Tetracycline derivatives as antibacterial agents |
| JP2011517697A (ja) | 2008-04-14 | 2011-06-16 | パラテック ファーマシューティカルズ インコーポレイテッド | 置換テトラサイクリン化合物 |
| CA2730377C (en) * | 2008-07-11 | 2017-09-19 | Neumedics | Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits |
| ES2558512T3 (es) | 2008-08-08 | 2016-02-04 | Tetraphase Pharmaceuticals, Inc. | Compuestos de tetraciclina sustituida con C7-fluoro |
| WO2010126607A2 (en) | 2009-04-30 | 2010-11-04 | President And Fellows Of Harvard College | Synthesis of tetracyclines and intermediates thereto |
| WO2010129055A1 (en) * | 2009-05-08 | 2010-11-11 | Tetraphase Pharmaceuticals, Inc. | 8-aza tetracycline compounds |
| WO2010129057A2 (en) | 2009-05-08 | 2010-11-11 | Tetraphase Pharmaceuticals, Inc. | Tetracycline compounds |
| US20120115819A1 (en) | 2009-05-13 | 2012-05-10 | Clark Roger B | Pentacycline Compounds |
| HUE037852T2 (hu) | 2009-08-28 | 2018-09-28 | Tetraphase Pharmaceuticals Inc | Tetraciklin-vegyületek |
| EP2544692A4 (en) | 2010-03-10 | 2013-08-07 | Univ Health Network | USE OF TIGECYCLIN FOR THE TREATMENT OF CANCER |
| JP5820462B2 (ja) | 2010-03-31 | 2015-11-24 | テトラフェース ファーマシューティカルズ，インコーポレイテッド | 多環式テトラサイクリン化合物 |
| AR082633A1 (es) | 2010-08-12 | 2012-12-19 | Tetraphase Pharmaceuticals Inc | Analogos de tetraciclina |
| WO2012047907A1 (en) | 2010-10-04 | 2012-04-12 | President And Fellows Of Harvard College | Synthesis of c5-substituted tetracyclines, uses thereof, and intermediates thereto |
| SMT201900096T1 (it) | 2012-08-31 | 2019-02-28 | Tetraphase Pharmaceuticals Inc | Composti di tetracicline |
| MA40836A (fr) | 2014-10-23 | 2017-08-29 | Tetraphase Pharmaceuticals Inc | Procédures de semi-synthèse |
| WO2017125557A1 (en) | 2016-01-22 | 2017-07-27 | Sandoz Ag | Crystalline eravacycline bis-hydrochloride |
| WO2018045084A1 (en) | 2016-08-30 | 2018-03-08 | Tetraphase Pharmaceuticals, Inc. | Tetracycline compounds and methods of treatment |
| MA46567A (fr) | 2016-10-19 | 2019-08-28 | Tetraphase Pharmaceuticals Inc | Formes cristallines de l'éravacycline |
-
2013
- 2013-08-30 SM SM20190096T patent/SMT201900096T1/it unknown
- 2013-08-30 NZ NZ74005113A patent/NZ740051A/en not_active IP Right Cessation
- 2013-08-30 PL PL13762660T patent/PL2890673T3/pl unknown
- 2013-08-30 SG SG10201801703RA patent/SG10201801703RA/en unknown
- 2013-08-30 HU HUE13762660A patent/HUE042600T2/hu unknown
- 2013-08-30 RS RS20190195A patent/RS58572B1/sr unknown
- 2013-08-30 US US14/424,765 patent/US9573895B2/en active Active
- 2013-08-30 MX MX2019004452A patent/MX390763B/es unknown
- 2013-08-30 SI SI201331346T patent/SI2890673T1/sl unknown
- 2013-08-30 WO PCT/US2013/057690 patent/WO2014036502A2/en not_active Ceased
- 2013-08-30 AU AU2013308504A patent/AU2013308504B2/en active Active
- 2013-08-30 EA EA201891804A patent/EA036088B1/ru unknown
- 2013-08-30 CA CA2883238A patent/CA2883238C/en active Active
- 2013-08-30 ME MEP-2019-48A patent/ME03329B/me unknown
- 2013-08-30 EP EP18192684.1A patent/EP3461809B1/en active Active
- 2013-08-30 PT PT13762660T patent/PT2890673T/pt unknown
- 2013-08-30 TR TR2019/02057T patent/TR201902057T4/tr unknown
- 2013-08-30 KR KR1020157008309A patent/KR102295673B1/ko active Active
- 2013-08-30 SG SG11201501516YA patent/SG11201501516YA/en unknown
- 2013-08-30 DK DK13762660.2T patent/DK2890673T3/en active
- 2013-08-30 CN CN201810192506.5A patent/CN108329312B/zh active Active
- 2013-08-30 HR HRP20190268TT patent/HRP20190268T1/hr unknown
- 2013-08-30 NZ NZ74559613A patent/NZ745596A/en not_active IP Right Cessation
- 2013-08-30 CN CN201810192454.1A patent/CN108276404A/zh active Pending
- 2013-08-30 LT LTEP13762660.2T patent/LT2890673T/lt unknown
- 2013-08-30 KR KR1020217026972A patent/KR102375238B1/ko active Active
- 2013-08-30 ES ES13762660T patent/ES2712476T3/es active Active
- 2013-08-30 EP EP13762660.2A patent/EP2890673B1/en active Active
- 2013-08-30 NZ NZ705849A patent/NZ705849A/en not_active IP Right Cessation
- 2013-08-30 BR BR112015004523-5A patent/BR112015004523B1/pt active IP Right Grant
- 2013-08-30 CN CN201380056726.0A patent/CN104768922B/zh active Active
- 2013-08-30 JP JP2015530126A patent/JP6301335B2/ja active Active
- 2013-08-30 MX MX2015002657A patent/MX364400B/es active IP Right Grant
- 2013-08-30 EA EA201590475A patent/EA031523B1/ru unknown
-
2015
- 2015-02-26 IL IL237437A patent/IL237437B/en not_active IP Right Cessation
-
2016
- 2016-10-18 AU AU2016247054A patent/AU2016247054B2/en not_active Ceased
-
2017
- 2017-01-06 US US15/400,674 patent/US10315992B2/en active Active
- 2017-02-08 AU AU2017200857A patent/AU2017200857B2/en active Active
-
2018
- 2018-02-28 JP JP2018034611A patent/JP6691157B2/ja active Active
-
2019
- 2019-02-14 CY CY20191100197T patent/CY1122744T1/el unknown
- 2019-04-24 US US16/393,725 patent/US10913712B2/en active Active
- 2019-05-19 IL IL266719A patent/IL266719A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013523761A5 (enExample) | ||
| MX385731B (es) | Compuestos de biaril-monobactam y métodos de uso de los mismos para el tratamiento de infecciones bacterianas. | |
| HRP20130928T1 (hr) | C7-fluor supstituirani spojevi tetraciklina | |
| JP2011530534A5 (enExample) | ||
| SA520411571B1 (ar) | مركبات كرومان مونوباكتام لعلاج العدوى البكتيرية | |
| HRP20210484T1 (hr) | Antimikrobna sredstva koja se temelje na imidazolu | |
| PH12022551444A1 (en) | Novel compounds and their use | |
| RU2013137752A (ru) | Твердые формы ингибитора гиразы (r)-1-этил-3-[6-фтор-5[2-(1-гидрокси-1-метил-этил) пиримидин-5-ил]-7-(тетрагидрофуран-2-ил)-1н-бензимидазол-2-ил] мочевины | |
| JP2020536966A5 (enExample) | ||
| JP2018524406A5 (enExample) | ||
| Flamm et al. | Ceftaroline activity tested against contemporary Latin American bacterial pathogens (2011) | |
| JP2016503778A5 (enExample) | ||
| PH12018500202A1 (en) | New effective aminoglycoside antibiotic for multidrug-resistant | |
| MX385203B (es) | Compuestos y métodos para tratar infecciones bacterianas. | |
| GEP20247641B (en) | Oxazolidinone compound and methods of use thereof as an antibacterial agent | |
| PE20181143A1 (es) | Compuestos para uso en aplicaciones antibacterianas | |
| JP2010507576A5 (enExample) | ||
| CY1124577T1 (el) | Καινοτομες ενωσεις τετραζολιου και η χρηση τους στη θεραπεια της φυματιωσης | |
| JP2024009968A5 (enExample) | ||
| RU2004117082A (ru) | Кетолидные 6-0-ацил-производные эритромицина в качестве антибактериальных средств | |
| WO2009001192A3 (en) | Novel compounds and their use | |
| EA201590876A1 (ru) | Спироизоксазолиновые соединения, обладающие активностью, усиливающей активность антибиотика | |
| JP2021516680A5 (enExample) | ||
| JP2008543964A5 (enExample) | ||
| JP2008546825A5 (enExample) |